Radka S F, Scott R G, Stewart S J
Hum Immunol. 1987 Apr;18(4):287-300. doi: 10.1016/0198-8859(87)90076-0.
In attempts to examine the relationships between serologic and structural polymorphisms of HLA-DQ molecules we have analyzed several monoclonal antibodies generated against polymorphic determinants on HLA-DQ molecules. One antibody, SFR20-DQw3, has a serologic reactivity like that of the previously characterized anti-DQw3-like monoclonal antibody, IVD12, but differs from IVD12 in its affinity for DQw3 molecules associated with DR4 and DRw9 haplotypes. Two other monoclonal antibodies have identical serologic and molecular specificity, and react with a subset of DQw3 positive cells; they have been designated SFR20-DQ beta 5. Biochemical analysis of the DQ molecules carried by DQw3-positive cell lines associated with different DR haplotypes (DR4, DR5, DRw8, DRw9, DRw12), reveal the presence of at least three different kinds of beta chains carrying the DQw3 epitope. All the cell lines bound by SFR20-DQ beta 5 (DR5, DRw8, and DRw12) possess DQ beta chains of indistinguishable electrophoretic mobility, which are different from the DQ beta chains of DQw3 cell lines not bound by this antibody while DQw3 beta chains carried by DR4 and DRw9 haplotypes are distinct from DQ beta 5-positive BLCL and from each other. The serologic reactivity of antibody DQ beta 5 correlates perfectly with an RFLP of the DQ beta gene designated DQw3.1 (Kim et al.: PNAS 828139, 1985), and with the serologic specificity TA10 as defined during the Ninth International Workshop (Schreuder GMT et al.: Histocompatibility Testing 1984). SFR20-DQ beta 5 reacts with a separated beta chain by Western blot analysis. The finding of indistinguishable beta chain electrophoretic mobility for all DQ beta 5/TA10 positive cell lines tested provide the molecular basis for these specificities, and strongly suggest that antibody SFR26-DQ beta 5 detects a single allele of the multiple DQ beta alleles which can contribute to the formation of the DQw3 specificity.
为了研究HLA - DQ分子的血清学多态性与结构多态性之间的关系,我们分析了几种针对HLA - DQ分子多态性决定簇产生的单克隆抗体。一种抗体SFR20 - DQw3,其血清学反应性与先前鉴定的抗DQw3样单克隆抗体IVD12相似,但在对与DR4和DRw9单倍型相关的DQw3分子的亲和力方面与IVD12不同。另外两种单克隆抗体具有相同的血清学和分子特异性,并与一部分DQw3阳性细胞发生反应;它们被命名为SFR20 - DQβ5。对与不同DR单倍型(DR4、DR5、DRw8、DRw9、DRw12)相关的DQw3阳性细胞系所携带的DQ分子进行生化分析,发现至少存在三种不同类型的携带DQw3表位的β链。所有被SFR20 - DQβ5结合的细胞系(DR5、DRw8和DRw12)都具有电泳迁移率无法区分的DQβ链,这与未被该抗体结合的DQw3细胞系的DQβ链不同,而DR4和DRw9单倍型所携带的DQw3β链与DQβ5阳性的B淋巴母细胞系不同,且彼此也不同。抗体DQβ5的血清学反应性与指定为DQw3.1的DQβ基因的限制性片段长度多态性(Kim等人:《美国国家科学院院刊》82:8139, 1985)以及第九届国际研讨会期间定义的血清学特异性TA10(Schreuder GMT等人:《组织相容性检测》1984)完全相关。通过蛋白质印迹分析,SFR20 - DQβ5与一条分离的β链发生反应。对所有测试的DQβ5/TA10阳性细胞系中β链电泳迁移率无法区分的发现为这些特异性提供了分子基础,并强烈表明抗体SFR26 - DQβ5检测到了多个可促成DQw3特异性形成的DQβ等位基因中的一个单一等位基因。